BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34756499)

  • 1. Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Jha R; Kurup A; Kovilapu UB; Ranjan R; Sondhi V
    Brain Dev; 2022 Feb; 44(2):166-172. PubMed ID: 34756499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
    Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
    Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR pathway activation in focal cortical dysplasia.
    Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic variants in new candidate genes identified in focal cortical dysplasia type II.
    Zhang Z; Gao K; Liu Q; Zhou J; Li X; Lang N; Liu M; Wang T; Zhang J; Wang H; Dong Y; Ji T; Wang S; Liu X; Jiang Y; Cai L; Wu Y
    Epilepsia; 2020 Apr; 61(4):667-678. PubMed ID: 32216069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
    Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
    Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
    Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
    Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE
    Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
    Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
    Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies.
    Ferri L; Menghi V; Licchetta L; Dimartino P; Minardi R; Davì C; Di Vito L; Cifaldi E; Zenesini C; Gozzo F; Pelliccia V; Mariani V; de Spelorzi YCC; Gustincich S; Seri M; Tassi L; Pippucci T; Bisulli F
    Epilepsy Behav; 2024 Apr; 153():109716. PubMed ID: 38508103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal Cortical Dysplasia and Refractory Epilepsy: Role of Multimodality Imaging and Outcome of Surgery.
    Jayalakshmi S; Nanda SK; Vooturi S; Vadapalli R; Sudhakar P; Madigubba S; Panigrahi M
    AJNR Am J Neuroradiol; 2019 May; 40(5):892-898. PubMed ID: 31000525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of S6 Protein as a Potential Biomarker in Surgically Treated Refractory Epilepsy.
    Chodraui FI; Garcia CAB; Mendes ND; Santos MV; Beggiora PS; Silva SC; Teixeira TL; da Silva Lopes L; Saggioro FP; Neder L; Machado HR
    Dev Neurosci; 2020; 42(5-6):230-236. PubMed ID: 33706310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of TSC2 mosaic mutation limited to cortical tuber with TSC targeted sequencing: a case report and literature review.
    Zhou Y; Wang X; Wang J; Ding Y; Wang Y; Li H; Zhao R; Wu B
    Childs Nerv Syst; 2021 Dec; 37(12):3945-3949. PubMed ID: 33517515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy surgery for focal cortical dysplasia: Seizure and quality of life (QOLIE-89) outcomes.
    Chaturvedi J; Rao MB; Arivazhagan A; Sinha S; Mahadevan A; Chowdary MR; Raghavendra K; Shreedhara AS; Pruthi N; Saini J; Bharath RD; Rajeswaran J; Satishchandra P
    Neurol India; 2018; 66(6):1655-1666. PubMed ID: 30504559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood-Onset Epileptic Encephalopathy Associated With Isolated Focal Cortical Dysplasia and a Novel TSC1 Germline Mutation.
    Hoelz H; Coppenrath E; Hoertnagel K; Roser T; Tacke M; Gerstl L; Borggraefe I
    Clin EEG Neurosci; 2018 May; 49(3):187-191. PubMed ID: 28762286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic
    Lee WS; Macdonald-Laurs E; Stephenson S; D'Arcy C; Maixner W; Harvey AS; Lockhart PJ; Leventer RJ
    Neurology; 2023 Jul; 101(2):78-82. PubMed ID: 37015817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.